Table 5 Summary of lung dose and critical organs for anatomic and functional treatment plans among 11 thoracic cancer patients
Metric | Anatomic planning | Functional planning |
|---|---|---|
Total lung | ||
V5 (%) | 42.77 ± 16.97 | 36.97 ± 17.05 |
V20(%) | 20.44 ± 6.99 | 18.12 ± 8.11 |
MLD (Gy) | 11.24 ± 4.03 | 10.19 ± 4.36 |
20% Functional lung | ||
V5 (%) | 34.76 ± 19.21 | 28.61 ± 19.45 |
V20(%) | 15.22 ± 8.59 | 12.57 ± 8.85 |
MLD (Gy) | 8.61 ± 4.35 | 7.38 ± 4.59 |
Heart | ||
V40 (%) | 16.75 ± 15.05 | 21.87 ± 23.12 |
Mean dose (Gy) | 16.7 ± 12.78 | 17.31 ± 13.95 |
Spinal cord | ||
Maximun (Gy) | 41.58 ± 5.73 | 43.31 ± 4.5 |
Esophagus | ||
V35 (%) | 20.36 ± 16.14 | 24.15 ± 17.36 |
V50 (%) | 11.57 ± 16.95 | 11.57 ± 16.96 |
Mean dose (Gy) | 15.34 ± 9.23 | 16.22 ± 9.31 |